The Motley Fool

Key Data Points

Primary metrics and data points about Epizyme.
Current Price: $14.39
Prev Close: $13.54
Open: $13.79
Bid: $14.33
Ask: $14.39
Day's Range: $13.15 - $14.60
52wk Range: $12.00 - $30.26
Volume: 229,600
Avg Vol 554,628
Market Cap: $595M
P/E (ttm): -4.07
EPS (ttm): ($3.33)
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for Epizyme.

Epizyme Inc is a clinical stage biopharmaceutical company that discovers develops and plans to commercialize personalized therapeutics for patients with genetically defined cancers.

  • Exchange: NASDAQ

Stock Charting

EPZM vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Epizyme.
CAPS Rating 4 out of 5
43 Outperform
5 Underperform
CAPS All Stars
17 Outperform
2 Underperform

Powered by Motley Fool CAPS

More Details about Epizyme

Primary metrics and data points about Epizyme.